Exposure to cisplatin in the operating room during hyperthermic intrathoracic chemotherapy

PURPOSE: Hyperthermic intrathoracic chemotherapy (HITOC) is an additive, intraoperative treatment for selected malignant pleural tumors. To improve local tumor control, the thoracic cavity is perfused with a cisplatin-containing solution after surgical cytoreduction. Since cisplatin is probably carc...

Descripción completa

Detalles Bibliográficos
Autores principales: Markowiak, Till, Ried, Michael, Larisch, Christopher, Nowak, Dennis, Hofmann, Hans-Stefan, Rakete, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8795016/
https://www.ncbi.nlm.nih.gov/pubmed/34191089
http://dx.doi.org/10.1007/s00420-021-01738-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8795016/
https://www.ncbi.nlm.nih.gov/pubmed/34191089
http://dx.doi.org/10.1007/s00420-021-01738-3

Ejemplares similares